Geneva, April 27 -- International Clinical Trials Registry received information related to the study (TCTR20260407006) titled 'Effects of pomegranate (Punica granatum) and Peganum harmala supplements on glycemic and lipid parameters in patients with Type 2 diabetes' on April 7.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: College of Pharmacy, University of Basrah, Iraq
Condition:
Type 2 Diabetes Mellitus
Punica granatum
Peganum harmala
Type 2 Diabetes Mellitus
Advanced glycation end products
Fructosamine
Blood glucose
Herbal supplementation
Punica granatum
Peganum harmala
Type 2 Diabetes Mellitus
Advanced glycation end products
Fructosamine
Blood glucose
Herbal supplementation
Intervention:
Participants co...